Abstract
Abstract
Introduction
: Stroke is one of the most devastating complications of sickle cell disease (SCD). Transcranial Doppler Imaging (TCDI) is the least invasive screening method to predict patients at risk for developing stroke in the disease. After a 10-year follow-up, we longitudinally assessed the TCDI in children with SCD without neurological symptoms.
Methods
25 out of 43 pediatric patients with SCD studied 10-year previously were recruited. The remaining 18 patient were not available for follow-up, but their initial data are presented for comparison. TCDI scanning was carried out using a phased-array transducer of 1–3 MHz through the trans-temporal window. Peak systolic velocity (PSV), end-diastolic velocity (EDV), time-averaged mean of the maximum velocity (TAMMV), resistive index (RI), and pulsatility index (PI) were obtained in the anterior and posterior Circle of Willis vessels.
Results
The highest initial and follow-up TAMMV (mean ± SD) were: 77.3 ± 20.9 and 71.6 ± 9.9 in the t-ICA, 94.3 ± 25.8 and 82 ± 18.2 in the MCA, 76.6 ± 25.6 and 70.6 ± 10.7 in the ACA, and 59.1 ± 15.8 and 63.9 ± 8.5 in the PCA, respectively. There was no statistically significant difference between initial and follow-up SCD data for all vascular parameters in all vessels on each side (P > 0.05) except for RI and PI (P < 0.05). There was significant correlation between TAMMV, PSV, and EDV (P = 0.001).
Conclusion
PSV, EDV can be used in parallel with TAMMV during TCDI. These vascular parameters do not suggest subclinical vascular deterioration.
Publisher
Research Square Platform LLC
Reference45 articles.
1. Adams RJ, Nichols FT. Sickle cell anemia, sickle cell trait, and thalassemia. In: Vinkin PJ, Bruyn GW, Klawans HL, editors. Handbook of clinical neurology: vascular diseases -Part III. New York, NY: Elsevier Science; 1989. pp. 505–15.
2. Adams RJ, Litaker ML, Nichols FT. Anemia and sickle cell disease. In: Babikia VL, Wechler LR, editors. Transcranial Doppler ultrasonography. St. Louis, MO: Mosby; 1993. pp. 160–71.
3. Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions;Kato GJ;Am J Hematol,2009
4. What's new in the pathophysiology of sickle cell disease?;Adekile AD;Med Princ Pract,2013
5. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes;Kato GJ;Blood Rev,2007